Feds: Top U. of C. doctor used insider knowledge of cancer drug to make stock market windfall – Chicago Tribune

According to the charges, Catenacci served as one of the lead physicians and primary field investigators on a clinical trial by a California-based biotechnology company, identified only as Company A. Through this position, Catenacci allegedly received confidential information about the company and its clinical trial results.

Leave a comment

Your email address will not be published. Required fields are marked *